18956075901
當前位置：上海富雨生物科技有限公司>>細胞庫 / 細胞培養>>干細胞>> TSU-Pr1人前列腺癌細胞、
TSU-Pr1 人前列腺癌細胞
Catalogue No.: C1418
Product Format: a T25 flask
Culture Properties：貼壁
Complete Growth Medium: 89%1640+10%FBS+1%雙抗
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Application: Cells and cancer research
NOTE: FOR RESEARCH USE ONLY.
Components
| Item | Specifications |
| a T25 flask | 2X106 |
| Manual | 1 copy |
anti-tumor immune response. It has been approved by the Food and Drug Administration (FDA) for the treatment of various tumor types, including melanoma, non-small cell lung cancer (NSCLC), head ａnd necksquamous cell carcinoma (HNSCC), and urothelial cancer (5). Clinical trials of ICB are currently being evaluated in NEN derived from different origins, including the gastrointestinal tract (GI), pancreas, and lung (6–9). In the phase II KEYNOTE-158 study, anti-PD-1
請輸入賬號
請輸入密碼
請輸驗證碼
以上信息由企業自行提供，信息內容的真實性、準確性和合法性由相關企業負責，化工儀器網對此不承擔任何保證責任。
溫馨提示：為規避購買風險，建議您在購買產品前務必確認供應商資質及產品質量。
化工儀器網